ReviewGels (Basel, Switzerland)2026
3D Printing with Tragacanth-Gum-Based Bioinks: A New Frontier in Bioprinting Materials.
Review in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Extrusion-based bioprinting is widely used for fabricating cell-laden constructs; however, its success is highly dependent on the rheological and biological performance of the bioink. Natural polysaccharide gums have emerged as promising bioink components due to their biocompatibility and tunable properties. Among them, tragacanth gum (TG), a complex anionic heteropolysaccharide composed of tragacanthin and bassorin fractions, has gained increasing attention for extrusion bioprinting applications. TG exhibits pronounced shear-thinning behavior, high water uptake, and spontaneous gel-forming ability, which collectively enhance the printability, shape fidelity, and structural stability of bioinks. This review critically summarizes recent advances in TG-based hydrogels and bioinks, with emphasis on their molecular characteristics, rheological and physicochemical properties, and biological performance in extrusion bioprinting systems. The role of TG as a functional component in composite bioinks, particularly in improving mechanical integrity, extrusion consistency, and cytocompatibility, is discussed. Finally, current challenges and future research directions are highlighted to support the development and clinical translation of TG-based bioinks for tissue engineering applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.